AI-enhanced precision medicine identifies novel autism subtype – Medical Xpress

A novel precision medicine approach enhanced by artificial intelligence (AI) has laid the groundwork for what could be the first biomedical screening and intervention tool for a subtype of autism, reports a new study from Northwestern University, Ben Gurion University, Harvard University and the Massachusetts Institute of Technology.
The approach is believed to be the first of its kind in precision medicine.
“Previously, autism subtypes have been defined based on symptoms onlyautistic disorder…

Click here to view the original article.